Testing Experimental Medication in Healthy Subjects
common.study.values.description
“CD71 in Dried Blood Spots in Healthy Males”
Understand the effect of recombinant EPO (rEPO) boosting and microdosing on the hematological module of the Athlete Biological Passport (ABP) - Measure the change in CD71 longitudinally in subjects from both cohorts - Assess whether rEPO administration can be detected in a dried blood spot (DBS) using recent advances in analytical methodologies - Compare windows of rEPO detection using both Athlete Biological Passport models and direct detection using analytical methods in urine, blood, and DBS
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - EPOGEN® (epoetin alfa)
Active drug
Normal Saline
Placebo
participant.views.study.view.additional
participant.views.study.view.scientific-title
Evaluation of CD71 Expression in a Dried Blood Spot Following rEPO Administration
common.study.values.clinical-trial-id
NCT04073849
participant.views.study.view.id
e0RzKb
